P0462 First-line treatment outcomes in metastatic Renal Cell Carcinoma (mRCC) patients with Pancreatic and/or Thyroid Metastases (PM/TM): Results from the IMDC

European Urology 2026

View at publisher
Authors: Martín Zarbá, E. Roussel, David Maj, Parker Baumgarten, C. Wells, Chehade R. El Hajj, Lisa Kinget, Edward Scott McTaggart, Giulia Mammone, Georg Arnold Bjarnason, J.L. Lee, L.A. Wood
+8 more Zeynep İrem Özay, Cristina Suárez, K. Takemura, Aly‐Khan A. Lalani, Thomas B. Powles, Toni K. Choueiri, Benoit Beuselinck, Dan Heng
DOI: 10.1016/s0302-2838(26)01349-7
Cited by: 0

Fields of Study & Subjects

Renal cell carcinoma treatment Bladder and Urothelial Cancer Treatments Ferroptosis and cancer prognosis

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S2
Publication date
13 February 2026
Language
EN